Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record■Insider buy□Insider sell◆Adverse 8-K filing●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Aug 20, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Aug 13, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
- Aug 13, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record26014 flagged findings
Reported transactions (Form 4)80since Apr 22, 2022 · and 8 other holdings
Corporate events (8-K)27since Dec 10, 2021
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
Regulatory history
Topics detected in its SEC reports, with the original excerpt.
Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.
- 2026-08-20listing compliance noticefreshOpen filing ↗“…Emerging growth company ☒ If an emerging growth company, indicate by check mark if the registrant has elected not to use the…”
+1 more passage from the same document
- “…Regains Compliance with Nasdaq Minimum Bid Price Requirement As previously disclosed, on December 31, 2025, RenovoRx, Inc.…”
- 2026-08-13share offering or dilution eventfreshOpen filing ↗“…results of operations and cash flows will be affected. Our critical accounting policies and estimates are detailed in our 2025…”
+1 more passage from the same document
- “…ended June 30, 2026, from those previously disclosed in our 2025 Annual Report. Convertible Instruments and Embedded Derivatives We…”
- 2026-08-13listing compliance noticefreshOpen filing ↗“…any time during the Second Compliance Period, the bid price of our common stock closes at or above $1.00 per share for a minimum of…”
+1 more passage from the same document
- “…days, Nasdaq will provide us with written confirmation of 33 compliance with the Minimum Bid Price Requirement and the matter will…”
- 2026-08-13reverse splitfreshOpen filing ↗“…we may be unable to timely satisfy the terms of any extension that may be granted by the Panel. We will continue to monitor the…”
+1 more passage from the same document
- “…bid price of our common stock and seek to regain compliance with all applicable Nasdaq requirements within the allotted…”
- 2026-07-02listing compliance noticerecentOpen filing ↗“…period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.…”
+1 more passage from the same document
- “…of this chapter). Emerging growth company ☒ If an emerging growth company, indicate by check mark if the registrant has…”
- 2026-05-15listing compliance noticerecentOpen filing ↗“…with the Minimum Bid Price Requirement and the matter will be closed. In the event we do not regain compliance with the…”
+1 more passage from the same document
- “…year. We were ultimately able to maintain our listing and raise capital to cure this listing deficiency. On December 31, 2025, we…”
- 2026-05-15reverse splitrecentOpen filing ↗“…we may be unable to timely satisfy the terms of any extension that may be granted by the Panel. We will continue to monitor the…”
+1 more passage from the same document
- “…bid price of our common stock and seek to regain compliance with all applicable Nasdaq requirements within the allotted…”
Original excerpts from SEC filings, untranslated. Not advice and not a prediction.
The 25 most recent filings (of 260)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Aug 20, 268-K ↗Current report · Other events
- Aug 13, 2610-Q ↗Quarterly report
- Aug 13, 268-K/A ↗Current report · Results · amendment
- Aug 12, 268-K ↗Current report · Financial statements and exhibits
- Aug 4, 268-K ↗Current report · Other events
- Jul 2, 268-K ↗Current report · Listing notice (8-K 3.01)
- Jun 30, 268-K ↗Current report · Shareholder vote results
- May 15, 2610-K/A ↗Annual report · amendment
- May 14, 2610-Q ↗Quarterly report
- May 14, 268-K ↗Current report · Results
- Apr 30, 26DEF 14A ↗Shareholder meeting and votes
- Apr 27, 26424B3 ↗Securities offering
- Apr 27, 26SCHEDULE 13G/A ↗Passive stake · Orin Hirschman · 9.8% · event on Mar 31, 26 · amendment
- Apr 23, 26CORRESP ↗Correspondence with the SEC
- Apr 22, 26UPLOAD ↗Correspondence with the SEC
- Apr 16, 26S-3 ↗Securities offering
260 filings on record, the oldest from May 3, 21.
Listing the 25 most recent filings of the 260 on record.
4914
- Jul 2, 26Listing notice (8-K 3.01)8-K 3.01 ↗
- Mar 27, 26A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Mar 23, 26Entered a material agreement+3 more in the same filing8-K 1.01 ↗
- Feb 6, 26A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Jan 2, 26Listing notice (8-K 3.01)8-K 3.01 ↗
- Nov 14, 25Entered a material agreement+1 more in the same filing8-K 1.01 ↗
- Feb 10, 25Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Aug 16, 24Auditor change filing (8-K Item 4.01)8-K 4.01 ↗
- Jun 7, 24A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- May 3, 24Auditor change filing (8-K Item 4.01)+2 more in the same filing8-K 4.01 ↗
- Apr 15, 24Sold unregistered shares+3 more in the same filing8-K 3.02 ↗
- Apr 9, 24Entered a material agreement+2 more in the same filing8-K 1.01 ↗
10 older filings not shown
Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.
- Feb 23, 24Listing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
- Aug 25, 23Listing notice (8-K 3.01)8-K 3.01 ↗
The full record holds 4 stress filings.
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- Orin Hirschman9.8%Mar 31, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
- HIRSCHMAN ORIN9.5%Mar 31, 25SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
- AWM Investment Company, Inc.2.4%Sep 30, 25SCHEDULE 13G/A ↗2 earlier filings
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
- May 19, 26Buy$20KMARK VOLLChief Financial Officer↗
- Mar 20, 26Buyamount n/aMARK VOLLChief Financial Officer↗
- Mar 20, 26Buyamount n/aShaun BagaiChief Executive Officer↗
- Mar 20, 26Buyamount n/aLaurence Marton↗
- Jan 21, 26Buy$10KRamtin AgahChief Medical Officer↗
- Dec 31, 25Buy$8KRamtin AgahChief Medical Officer↗
- Dec 30, 25Buy$169Ramtin AgahChief Medical Officer↗
- Dec 18, 25Buy$5KShaun BagaiChief Executive Officer↗
- Dec 17, 25Buy$4KShaun BagaiChief Executive Officer↗
- Dec 16, 25Buy$10KRamtin AgahChief Medical Officer↗
- Dec 5, 25Buy$10KRamtin AgahChief Medical Officer↗
- Nov 24, 25Buy$10KRamtin AgahChief Medical Officer↗
There are 22 more transactions in this stretch.
Stock compensation, tax and giftsshow the 6 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
- Sep 10, 26Compensationamount n/aMARK VOLLChief Financial Officer↗
- Apr 3, 26Compensationamount n/aMARK VOLLChief Financial Officer↗
- Mar 25, 26Compensationamount n/aMARK VOLLChief Financial Officer↗
- May 2, 25Compensation$3KLaurence Marton↗
- Apr 22, 25Giftamount n/aRamtin AgahChief Medical Officer↗
- Apr 22, 22Other$25KUNA S RYAN↗
The full record holds 43 transactions and goes back to Mar 3, 22.
Its sector and its market
RenovoRx Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From RenovoRx Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow RenovoRx Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- 250 clean closes in the period.
- SEC records
- 260 documents on file, from May 3, 2021 to Oct 2, 2026.
- Company description
- No description available.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.